Recent Analyst Forecasts and Stock Ratings
Neurocrine Biosciences, Inc. FAQ's
What analysts cover Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. has been rated by research analysts at BMO Capital, Oppenheimer, Raymond James, Barclays, RBC Capital, Piper Sandler in the past 90 days.